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INTRODUCTION 
 
Lactoferrin (LF) is a glycoprotein that belongs to iron transporter or transferrin family. It was 
originally isolated from bovine milk, where it is found as a minor protein component of whey 
proteins. LF contains 703 amino acids and has a molecular weight of ca. 80 kDa. In addition to its 
presence in milk, it is also found in exocrine secretions of mammals and is released from neutrophil 
granules during inflammation. It is considered a multifunctional or multi-tasking protein, and 
appears to play several biological roles. Owing to its iron-binding properties, LF is thought to play a 
role in iron uptake by the intestinal mucosa of the suckling neonate, which make it a potential 
source of iron for breast-fed infants. Additionally, LF showed to have antibacterial, antiviral, 
antifungal, anti-inflammatory, antioxidant and immunomodulatory activities (Yamauchi et al., 
1993; Ward et al., 2002). Bovine LF, derived from whey proteins, is marketed as a nutritional 
supplement. The development of strategies that may permit structural and functional stabilization of 
LF via nanoencapsulation may increase the biopharmaceutical applicability of this bioactive 
protein. Such LF-encasing nanovesicles could be utilized in the formulation of dental elixirs to 
eliminate the oral microflora responsible for formation of oral biofilms with one clear advantage: 
the adhesive nanovesicles could slowly liberate its naturally antimicrobial content, thus reducing the 
development of dental cavities. Water-in-oil-in-water emulsions are examples of multiple 
emulsions, in which dispersions of small water droplets within larger oil droplets are themselves 
dispersed in a continuous aqueous phase (Bibette et al., 1999; Ficheux et al., 1998; Wang et al., 
2006; Hanson et al., 2008). Emulsions are quite utilized in many ways of processing, and are 
extensively used by the food, cosmetic, and coating industries. Due to their compartimentalized 
internal structure, multiple emulsions present advantages over simple oil-in-water (O/W) emulsions 
for encapsulation, such as the ability to carry both polar and non-polar molecules, and a better 
control over releasing of therapeutic molecules (Pays et al., 2002; Davis and Walker, 1987; Okochi 
and Nakano, 2000). In the present research work, the potential of natural antimicrobial, bovine LF, 
stabilized via nanoencapsulation for incorporation in a mouth wash elixir has been investigated. 
Bovine LF was entrapped within water-in-oil-in-water (W/O/W) multiple nanoemulsions, aiming at 
mimicking the multifunctional design of biology, with several lipid matrices, and stabilizing layer 
compositions. The composition of the stabilizing layer of the nanosystem was changed by using 
different proportions of lecithin and different poloxamers (nonionic triblock copolymers with a 
central hydrophobic core of polyoxypropylene flanked by two hydrophilic chains of 
polyoxyethylene), thus allowing to control degradation times of the nanovesicles. For the 
production of nanoemulsions, bioactive compounds were previously dissolved in the aqueous phase 
prior to be dispersed in the melted lipid during homogenization in a UltraTurrax (model T25D from 
IKA) under heating (ca 40 °C). The resulting nanoemulsions were subsequently fully characterized 
physicochemically. Physicochemical characterization of the optimized nanovesicle formulations 
encasing the bioactive LF encompassed determination of particle size, size distribution and particle 
charge, via Zeta potential analysis, surface morphology via scanning electron microscopy (SEM), 
protein encapsulation efficiency via spectrophotometric analysis, and thermal analysis via 
Differential Scanning Calorimetry (DSC). The antimicrobial activity of the nanoemulsions were 
also assessed in vitro, upon several microbial strains in liquid medium, including pathogenic 
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bacteria and Candida albicans. The use of these multiple nanoemulsions in formulating elixirs for 
oral hygiene would possess inherent advantages, when compared with the current chemical 
antimicrobial formulations, in that LF is a naturally harmless protein with bacteriostatic activity, 
without toxicological risk even for small children. 
 
 
MATERIALS AND METHODS 
 
Preparation of multiple LF-encasing nanoemulsions. Production of multiple nanoemulsions 
(water-in-oil-in-water, W/O/W) with nanoencapsulated LF was carried out in an UltraTurrax 
(model T25D from IKA) under heating (ca 40 °C), with the bioactive LF being previously dissolved 
in the (inner) aqueous phase (W) prior to being dispersed in the melted lipid (Softisan, from Sasol 
Olefins & Surfactants GmbH, Hamburg, Germany) during homogenization (10 min at 8000 rpm). 
Therefore, final W/O/W dispersion of LF was obtained via a sequential (optimized) homogenization 
of a W/O dispersion involving two cycles for 10 min. The inner aqueous phase was constituted by 
HCl 10 mM (from Vaz Pereira), CaCl2 20 mM (from Merck), Tween 80 (from Sigma-Aldrich) and 
pure bovine lactoferrin (from DMV International) (with concentrations ranging from 25 mg to 250 
mg); the intermediate oily phase encompassed glycerol (from Merck, Darmstadt, Germany), 
Softisan (or Precirol or Compritol, from GatteFossé) and soybean phosphatidylcholine (from 
Acofarma); finally, the outer aqueous phase encompassed Lutrol 68 (poloxamer 188 from BASF), 
ultrapure water and NaCl (from Vaz Pereira, Portugal) 10 mM. Control nanoparticles were also 
produced, without LF, and stored for 52 days under the same conditions. 
 
Evaluation of the combined effects of homogenization time, LF concentration and ionic 
strength of the outer aqueous phase. The stability of the multiple nanoemulsions was evaluated 
by producing emulsions as result of the combined effect of homogenization time (5, 10 and 20 
min), LF concentration (25, 50, 100 and 250 mg) and ionic strength (NaCl 1, 10 and 100 mM) of 
the aqueous outer phase 
 
Determination of hydrodynamic size and Zeta potential. Zeta potential is the electric potential 
that prevails in the cutting plan of a particle, which is at a small distance from its surface, and which 
results from the measure of the mobility distribution of a dispersion of charged particles as they are 
subject to an electric field. The mobility can be defined as the velocity of a particle per unit electric 
field, and is determined by applying an electric field to the dispersion of particles and measuring 
their average velocity. The results obtained allow determination of the hydrodynamic size of the 
lipid vesicles, of the polydispersion index and of their Zeta potential. The Zeta potential and 
hydrodynamic size of the nanoemulsion particles were determined in a Zetasizer (model Nanoseries 
Nano-ZS) from Malvern Instruments. 
 
Thermal analysis by differential scanning calorimetry (DSC). Calorimetric analysis was 
performed in a differential scanning calorimeter (Shimadzu, Kyoto, Japan). For every calorimetric 
assay, ca. 10 mg of emulsion were weighed (using a microsyringe) directly into the interior of high-
pressure aluminum pans (Shimadzu, P/N 557 201-53090, 64U3670609), and duly sealed by 
pressure. A reference aluminum pan was also prepared by simply sealing air inside an empty case. 
The samples were then heated from room temperature to 100 °C at a constant linear scanning rate 
of 5 °C/min, during which the amount of heat absorbed by the sample was recorded. 
 
Protein encapsulation efficiency. Protein encapsulation efficiency was determined via 
spectrophotometric analysis of the supernatants, following centrifugation of the nanoemulsions 
using Centricon tubes (from Millipore). 
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Antimicrobial activity of LF and multiple nanoemulsions. Screening of antimicrobial activity 
was determined by the diffusion method. Inocula of each target microorganism - Staphylococcus 
aureus, Salmonella sp., Escherichia coli, Pseudomonas aeruginosa, Listeria innocua and Bacillus 
cereus, and of Candida albicans were prepared by suspension of a pure colony in 0.9 % sterile 
NaCl (to reach a standard turbidimetry of 0.5 McFarland). Each suspension was inoculated in 
Mueller Hinton Agar, and after drying, separated wells were made in the plates, and 60 !L of 
different nanoemulsion samples and controls were added. Sterile water was used as negative 
control, and antibiotics as positive controls (chloramphenicol for St. aureus, Salmonella sp., E. coli, 
P. aeruginosa, B.s cereus and ampicillin for L. innocua). Each plate was incubated at 37 °C for 24 
h, after which the inhibition halos were measured. In the case of pure LF and nanoemulsion samples 
with antimicrobial activity, Minimum Inhibitory Concentration (MIC) was determined by 
microplate assay, using same target microorganisms and inocula as described previously. Each 
suspension of microorganism was inoculated in 96-well plates containing Mueller Hinton Broth for 
bacteria and Yeast Malt Broth for yeast, with different LF concentrations (2000, 1000, 500, 250, 
125 !g mL
-1
).  Sterile water was used as negative control and uninoculated media were used as a 
positive control. The plates were incubated at 37 °C for 24 h, and optical density was measured by 
plate reader at 620 nm. The MIC was determined as the lowest concentration of LF (free or in 
nanoemulsion) that showed absence of turbidimetry when compared with the positive control. 
 
 
RESULTS AND DISCUSSION 
 
The net charge of each particle surface affects the distribution of ions in the surroundings, thus 
forming an electrical double layer around each (nano)particle. When a particle moves, ions within 
the boundary move with it, and vice versa. Zeta potential is the potential that exists at this 
boundary, and its intensity is an indication of the potential stability in the colloidal system, and can 
be measured by determination of the linear velocity of the particles in an electric field. The Zeta 
potential depends on the concentration of ions in the solvent. The main reason why to measure the 
Zeta potential lies in predicting colloidal stability, which in turn depends on the interactions 
between particles. Zeta potential is therefore an attempt to quantify such interactions, by predicting 
stability. The Zeta potential is a measure of the repulsive forces between particles, and since the 
majority of colloidal aqueous systems is stabilized via electrostatic repulsion, the larger the 
repulsive forces between particles the smaller the probability for them to become closer and form 
aggregates, leading to a more stable colloidal system. The mean size and size distribution 
(polydispersity index) were measured via Dynamic Laser light Scattering (suitable for particles 
ranging from 5 nm to ca. 3 !m). DSC measurements provided an insight into the state and degree of 
cristallinity, and the melting and crystallization behaviour of crystalline materials such as the 
nanovesicles produced. The amount of heat absorbed by the lipid vesicles was the same when 
comparing empty vesicles and vesicles incorporating LF, for a homogenization period of 10 
minutes. Also, increasing homogenization time led to nanovesicles that exhibited an increase in the 
amount of heat absorbed by the particles, probably due to a reduction in size and/or to liberation of 
LF. The antimicrobial activity of the different nanoemulsions, assessed in vitro against several 
microbial strains showed different efficiency depending on the pathogenic microorganism. Buffered 
LF was found to be more stable than unbuffered, purified LF. Several variables were studied, viz. 
lipid nature, poloxamer concentration, soy lecithin concentration, homogenization time, and LF 
concentration. Centrifugation of the optimized nanoformulations did not lead to any LF liberation 
induced by bursting nanovesicles (as revealed by UV-VIS spectrophotometry), thus evidencing the 
firm encapsulation and concomitant structural stabilization of LF. Increasing LF concentration lead 
to an increase in the values of Zeta potential (from negative to positive values). Optimum 
homogenization time was found to be 10 minutes, at 8000 rpm, since during such timeframe 
particle size was maintained at values ranging from 100 – 200 nm. Addition of an electrolyte 
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(sodium chloride) to the external aqueous phase also leads to an increase in the values of Zeta 
potential. However, when using a higher (100 mM) electrolyte concentration, phase separation was 
notorious immediately after homogenization. Increasing electrolyte concentration leads to an 
increase in the values of zeta potential, presumably due to accumulation of adsorbed ions at the 
particle surfaces. Addition of electrolyte at concentrations of 1 mM proved to be most suitable by 
producing nanovesicles with stable Zeta potential over time. Storage of the optimized multiple 
nanoemulsions (with Softisan, due to its mild melting temperature) throughout 63 d at room 
temperature led to an increase in Zeta potential values, presumably due to ion concentration at 
particle interface. Control nanoparticles were also produced, without LF, and stored for 52 days 
under the same conditions; for these, a slight increase in particle size was noticed, together with a 
slight increase in Zeta potential values. Regarding particle size, no change was observed in the 
range of 100 – 200 nm. Precirol and Compritol were also tested as lipids for the oily phase, but 
owing to their high melting points, they were discarded in order to prevent deactivation of LF. 
 
 
CONCLUSIONS 
 
In this research effort, development and optimization of lipid nanoparticles encasing LF was 
pursued. A lipid with mild melting temperature was found most appropriate for the discontinuous 
oily phase. A homogeneization timeframe of 10 min, the use of an electrolyte with a low ionic 
strength, and low LF concentrations were found to be critical variables for producing stable 
nanovesicle dispersions with diameters ranging from 100-200 nm and Zeta potential values of ca. -
14.6 mV. The use of these multiple nanoemulsions in formulating elixirs for oral hygiene would 
possess inherent advantages, when compared with the current chemical antimicrobial formulation, 
in that LF is a naturally harmless protein with bacteriostatic activity. 
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